IBRX
Immunitybio Inc. Earnings
$2.01
Earnings Summary
Revenue | $7.55Mn |
Net Profits | $-59.16Mn |
Net Profit Margins | -783.4% |
Immunitybio Inc.’s revenue jumped 5333.09% since last year same period to $7.55Mn in the Q4 2024. On a quarterly growth basis, Immunitybio Inc. has generated 23.68% jump in its revenue since last 3-months.
Immunitybio Inc.’s net profit jumped 74.65% since last year same period to $-59.16Mn in the Q4 2024. On a quarterly growth basis, Immunitybio Inc. has generated 30.99% jump in its net profits since last 3-months.
Immunitybio Inc.’s net profit margin jumped 99.53% since last year same period to -783.4% in the Q4 2024. On a quarterly growth basis, Immunitybio Inc. has generated 44.2% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.16 |
EPS Estimate Current Year | -0.16 |
Immunitybio Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.16 - a -23.08% fall from last quarter’s estimates.
Immunitybio Inc.’s earning per share (EPS) estimates for the current year stand at -0.16.
Key Ratios
Earning Per Share (EPS) | -0.08 |
Immunitybio Inc.’s earning per share (EPS) jumped 77.14% since last year same period to -0.08 in the Q4 2024. This indicates that the Immunitybio Inc. has generated 77.14% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-12 | -0.17 | -0.2 | -17.65% |
2024-11-12 | -0.18 | -0.12 | 31.56% |
2025-03-03 | -0.13 | -0.08 | 38.46% |
2024-05-09 | -0.16 | -0.2 | -25% |
